Patents

Cortex has filed over 400 composition-of-matter and broad use patents with 200 issued or allowed in the U.S. and offshore.  They include a combination of composition of matter patents, as well as broad use patents, based on the mechanism of action of AMPAKINE compounds, i.e., any compound that binds to the AMPA receptor and increases AMPA receptor modulation.  The mechanism-based patents cover uses such as improving memory and cognition, treating schizophrenia, age-related decline in libido, and up-regulating neurotrophic factors in the brain.